Predictors and the subsequent risk of end-stage renal disease –Usefulness of 30% decline in estimated GFR over 2 years.
Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S.
PLoS One. 2015 Jul 15;10(7):e0132927.